NCT03137940

Brief Summary

The study aims to evaluate the safety and the feasibility of transcranial Direct Current Stimulation (tDCS) session in children and young adults with Unilateral Cerebral Palsy (UCP). Secondarily it aims to test the effects of tDCS (real vs sham) in improving, in very short term, Upper Limb (UL) functions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2017

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

April 18, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 3, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2017

Completed
Last Updated

August 8, 2019

Status Verified

August 1, 2019

Enrollment Period

7 months

First QC Date

April 18, 2017

Last Update Submit

August 7, 2019

Conditions

Keywords

Unilateral Cerebral PalsytDCSSafetyUpper Limb functions

Outcome Measures

Primary Outcomes (1)

  • Incidence of Treatment Emergent Adverse Events [Safety and Tolerability]

    An adapted and child-friendly safety and tolerability questionnaire will be used for children and adolescent, while for young adults a questionnaire already used for this evaluation will be proposed. To explore the long-term safety the questionnaire is enriched with questions about quality of sleep, mood and activities to be answered after 24 hours of tDCS session

    The questionnaire will be filled in immediately after the tDCS session (T1), at 1 hour and half from T1 (T2) and, on call, at 24 hours from the tDCS session (T3)

Secondary Outcomes (4)

  • Changes in heart rate [heartbeats per minute]

    At baseline (T0, before the tDCS session), immediately after the tDCS session (i.e. 20 minutes after T0), at 1 hour and half from T1 (T2)

  • Changes in blood pressure [mmHg]

    At baseline (T0, before the tDCS session), immediately after the tDCS session (i.e. 20 minutes after T0), at 1 hour and half from T1 (T2)

  • Changes in Box and Block Test (BBT)

    At baseline (T0, before the tDCS session), immediately after the tDCS session (i.e. 20 minutes after T0), at 1 hour and half from T1 (T2)

  • Changes in Hand Grip

    At baseline (T0, before the tDCS session), immediately after the tDCS session (i.e. 20 minutes after T0), at 1 hour and half from T1 (T2)

Study Arms (2)

real tDCS

EXPERIMENTAL

one-shot of real tDCS session (1.5mA; 0.06 mA/cm2 for 20 minutes) with BrainStim Stimulator. The anode electrode is placed in a primary motor cortex (M1) of ipsilesional hemisphere (EEG 10/20 system), while cathode is placed in the supraorbital region (SO) of the contralateral hemisphere.

Device: real tDCS

Sham tDCS

SHAM COMPARATOR

one-shot of sham tDCS session with BrainStim Stimulator (20 minutes). The montage of the electrodes will be placed as in the experimental session i.e.the anode electrode will be placed in a primary motor cortex (M1) of ipsilesional hemisphere (EEG 10/20 system), while cathode in the supraorbital region (SO) of the contralateral hemisphere.

Device: sham tDCS

Interventions

real tDCSDEVICE

one-shot of real tDCS session (1.5mA; 0.06 mA/cm2 for 20 minutes) with BrainStim Stimulator.

real tDCS
sham tDCSDEVICE

one-shot of sham tDCS session (20 minutes) with BrainStim Stimulator.

Sham tDCS

Eligibility Criteria

Age10 Years - 28 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Symptomatic Unilateral Cerebral Palsy
  • Informed consent

You may not qualify if:

  • Any contraindication for tDCS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Fondazione Stella Maris

Calambrone, Pisa, Italy

Location

Related Publications (1)

  • Inguaggiato E, Bolognini N, Fiori S, Cioni G. Transcranial Direct Current Stimulation (tDCS) in Unilateral Cerebral Palsy: A Pilot Study of Motor Effect. Neural Plast. 2019 Jan 15;2019:2184398. doi: 10.1155/2019/2184398.

Study Officials

  • Giovanni Cioni, MD

    IRCCS Fondazione Stella Maris, Università di Pisa

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The medical device randomly assigns, to each subject, the sequence of the type of sessions, so no one knows the kind of session performed.
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: Each subject receives, randomly, a real session of tDCS and a sham session with BrainStim Stimulator.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 18, 2017

First Posted

May 3, 2017

Study Start

March 20, 2017

Primary Completion

October 20, 2017

Study Completion

December 30, 2017

Last Updated

August 8, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations